GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Market Cap

Appili Therapeutics (Appili Therapeutics) Market Cap : $2.66 Mil (As of May. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Appili Therapeutics's share price for the quarter that ended in Dec. 2023 was $0.0265. Appili Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 121.27 Mil. Therefore, Appili Therapeutics's market cap for the quarter that ended in Dec. 2023 was $3.21 Mil.

Appili Therapeutics's quarterly market cap increased from Jun. 2023 ($2.67 Mil) to Sep. 2023 ($5.03 Mil) but then declined from Sep. 2023 ($5.03 Mil) to Dec. 2023 ($3.21 Mil).

Appili Therapeutics's annual market cap declined from Mar. 2021 ($54.62 Mil) to Mar. 2022 ($6.97 Mil) and declined from Mar. 2022 ($6.97 Mil) to Mar. 2023 ($3.07 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Appili Therapeutics's Enterprise Value for Today is $8.54 Mil.


Appili Therapeutics Market Cap Historical Data

The historical data trend for Appili Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Market Cap Chart

Appili Therapeutics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Market Cap
Get a 7-Day Free Trial - - 54.62 6.97 3.07

Appili Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.37 3.07 2.67 5.03 3.21

Competitive Comparison of Appili Therapeutics's Market Cap

For the Biotechnology subindustry, Appili Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Appili Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Appili Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Appili Therapeutics's Market Cap falls into.



Appili Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Appili Therapeutics's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )=Share Price (A: Mar. 2023 )*Shares Outstanding (EOP) (A: Mar. 2023 )
=$0.0253*121.266
=$3.07

Appili Therapeutics's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=$0.0265*121.266
=$3.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Appili Therapeutics  (OTCPK:APLIF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Appili Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Appili Therapeutics (Appili Therapeutics) Business Description

Traded in Other Exchanges
Address
1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.